Predictors of In-Hospital Mortality in Patients with Acute Ischemic Stroke Treated with Thrombolytic Therapy
JAMA 292:1831-1838, Heuschmann,P.U.,et al, 2004
Lack of Improvement in Patients with Acute Stroke After Treatment with Thrombolytic Therapy
JAMA 292:1839-1844, Saposnik,G.,et al, 2004
Long-Term Outcome After Intravenous Thrombolysis of Basilar Artery Occlusion
JAMA 292:1862-1866, Lindsberg,P.J.,et al, 2004
PROTECT A Coordinated Stroke Treatment Program to Prevent Recurrent Thromboembolic Events
Neurol 63:1217-1222, Ovbiagele,B.,et al, 2004
Ventriculoperitoneal Shunting for Idiopathic Intracranial Hypertension
Neurol 63:1314-1316, Bynke,G.,et al, 2004
Intravenous Immunoglobulin Treatment Following the First Demyelinating Event Suggestive of Multiple Sclerosis
Archn Neurol 61:1515-1520, Achiron,A.,et al, 2004
Effect of Intravenous Corticosteroids on Death Within 14 Days in 10008 Adults with Clinically Significant Head Injury (MRC CRASH Trial): Randomised Placebo-Controlled Trial
Lancet 364:1321-1328,1291, CRASH Trial Collaborators, 2004
Diffusion-Weighted Imaging in the Assessment of Brain Abscesses Therapy
AJNR 25:1310-1317,1303, Cartes-Zumelzu,F.W.,et al, 2004
Protected Carotid-Artery Stenting Versus Endarterectomy in High-Risk Patients
NEJM 351:1493-1501,1565, Yadav,J.S.,et al, 2004
Narcolepsy and Excessive Daytime Sleepiness
BMJ 329:724-728, Zeman,A.,et al, 2004
The Shape of Things to Come
Neurol 63:948-950, Hauser,S.L., 2004
Slippery Slopes, Wonder Drugs, and Cosmetic Neurology
Neurol 63:951-952, Dees,R.H., 2004
Practice Parameter: Treatment of Postherpetic Neuralgia
Neurol 63:959-965, Dubinsky,R.M.,et al, 2004
The Bioavailability of IV Methylprednisolone and Oral Prednisone in Multiple Sclerosis
Neurol 63:1079-1080, Morrow,S.A.,et al, 2004
Plasma Exchange for Severe Optic Neuritis
Neurol 63:1081-1083, Ruprecht,K.,et al, 2004
Natural History of Conservatively Treated Meningiomas
Neurol 63:1133-1134, Herscovici,A.,et al, 2004
The MATCH Study Results in the Context of Secondary Stroke Prevention
Stroke 35:2609, Fisher,M. &Davalos,A., 2004
Thoughts Evoked by MATCH and Other Trials
Stroke 35:2604-2605, Caplan,L.R., 2004
Treatment of Constipation and Fecal Incontinence in Stroke Patients
Stroke 35:2549-2555, Harari,D.,et al, 2004
Transient Ischemic Attacks Are More Than "Minitrokes"
Stroke 35:2453-2458, Daffertshofer,M.,et al, 2004
Risk of General Anaesthesia in People With Obstructive Sleep Apnoea
BMJ 329:955-959, den Herder,C.,et al, 2004
Donepezil Improved Memory in Multiple Sclerosis in a Randomized Clinical Trial
Neurol 63:1579-1585, Krupp,L.B.,et al, 2004
Ulnar Neuropathy at the Elbow
Neurol 63:1675-1680, Beekman,R.,et al, 2004
Treatment of Trigeminal Neuralgia Associated with Multiple Sclerosis
Neurol 63:1714-1715, Rasche,D.,et al, 2004
Bell's Palsy
NEJM 351:1323-1331, Gilden,D.H., 2004
Thrombylosis for Cerebral Vein and Dural Sinus Thrombosis
Stroke 35:2428, Ciccone,A.,et al, 2004
Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial
Stroke 35:2418-2424, Ingall,T.J.,et al, 2004
Combined Anticoagulant-Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients
Stroke 35:2362-2367, Shireman,T.I.,et al, 2004
Expanding the Range of Therapies for Acute Ischemic Stroke: The Early Experience of the Regional Stroke Center at Hartford Hospital
Connecticut Medicine 68:419-429, Silvernman,I.E.,et al, 2004
Interferon Beta-1a for Brain Tissue Loss in Patients at Presentation with Syndromes Suggestive of Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:1489-1496,1463, Filippi,M.,et al, 2004
Clinical Features and Prognostic Factors in Adults with Bacterial Meningitis
NEJM 351:1849-1859,1826, van de Beek,D.,et al, 2004
Bacterial Meningitis--A View of the Past 90 Years
NEJM 351:1826-1828, Swartz,M.N., 2004
Clinicopath Conf, Anaplastic Oligodendroglioma with Allelic Loss of Chromosomes 1p and 19q
NEJM 351:1875-1882, Case 33-2004, 2004
Sequential Combination of Intravenous Recombinant Tissue Plasminogen Activator and Intra-Arterial Urokinase in Acute Ischemic Stroke
AJNR 25:1470-1475, Lee,K.Y.,et al, 2004
A Double-blind Placebo-controlled Trial of Botulinum Toxin B for Sialorrhea in Parkinson's Disease
Neurol 62:37-40, Ondo,W.G.,et al, 2004
Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke
Stroke 35:147-150, Brown,D.L.,et al, 2004
Steroids Have No Role in Stroke Therapy
Stroke 35:229-231, Poungvarin,N.,et al, 2004
Steroids May Have a Role in Stroke Therapy
Stroke 35:228-229,230, Norris,J.W., 2004
Surgical and Hardware Complications of Subthalamic Stimulation
Neurol 63:612-616, Lyons,K.E.,et al, 2004
Economic Evaluation of Donepezil in Moderate to Severe Alzheimer Disease
Neurol 63:644-650, Feldman,H.,et al, 2004
Efficacy of Donepezil in Mild Cognitive Impairment
Neurol 63:651-657, Salloway,S.,et al, 2004
Seizure Outcomes After Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations
Neurol 63:683-687, Schauble,B.,et al, 2004
Efficacy of Mycophenolate Mofetil in Patients with Chronic Immune Demyelinating Polyneuropathy
NEruol 63:715-717, Gorson,K.C.,et al, 2004
Melatonin, 3 mg, is Effective for Migraine Prevention
Neurol 63:757, Peres,M.F.P.,et al, 2004
HSV-2 Sacral Radiculitis (Elsberg Syndrome)
Neurol 63:758-759, Eberhardt,O.,et al, 2004
Recent Developments in Thyroid Eye Disease
BMJ 329:385-390, Cawood,T.,et al, 2004
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004
Does Transcatheter Closure of Patent Foramen Ovale Really "Shut the Door?"
Stroek 35:2140, Anzola,G.P.,et al, 2004
European Study on Intravenous Immunoglobulin in Multiple Sclerosis
Arch Neurol 61:1409-1412, Filippi,M.,et al, 2004
Botulinum Toxin Type A for Treating Voice Tremor
Arch Neurol 61:1416-1420, Adler,C.H.,et al, 2004